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Dieting often leads to body weight cycling involving repeated weight loss and regain. However, little
information is available regarding rapid-response serum markers of overnutrition that predict body
weight alterations during weight cycling. Here, we report the rapid response of serum leukocyte cell-
derived chemotaxin 2 (LECT2), a hepatokine that induces insulin resistance in skeletal muscle, during
diet-induced weight cycling in mice. A switch from a high-fat diet (HFD) to a regular diet (RD) in obese
mice gradually decreased body weight but rapidly decreased serum LECT2 levels within 10 days. In
contrast, a switch from a RD to a HFD rapidly elevated serum LECT2 levels. Serum LECT2 levels showed a
positive correlation with liver triglyceride contents but not with adipose tissue weight. This study
demonstrates the rapid response of LECT2 preceding body weight alterations during weight cycling in
mice and suggests that measurement of serum LECT2 may be clinically useful in the management of
obesity.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Dieting-induced body weight loss is an effective treatment for
obesity-associated diseases, such as type 2 diabetes and fatty liver
disease [1,2]. However, dieting often leads to body weight cycling,
i.e., repeated cycles of intentional weight loss and subsequent
weight gain [3]. There are conﬂicting data regarding the relation-
ship between weight cycling and future onset of metabolic disor-
ders [4], but weight cycling may lead to further weight gain [5] and
the development of insulin resistance [6]. Similarly, an early large-
scale clinical trial indicated that weight cycling increased the risk oflogy and Metabolism, Kana-
s, 13-1 Takara-machi, Kana-
), ttakamura@m-kanazawa.jp
r Inc. This is an open access articlonset of type 2 diabetes compared with no weight cycling over a
net weight gain in German participants [7]. To avoid the onset of
body weight cycling and to achieve long-term body weight
reduction in obese individuals, the development of rapid-response
serummarkers to predict body weight alterations may be useful for
health professionals to perform early clinical interventions.
We have recently identiﬁed leukocyte cell-derived chemotaxin
2 (LECT2, encoded by LECT2 in humans) as a hepatokine that is
overproduced in obesity [8]. LECT2 was originally reported to be a
neutrophil chemotactic protein expressed mainly in human adult
and fetal hepatocytes [9]. However, we found a positive correlation
between hepatic LECT2 expression and body mass index (BMI) in
humans via a screening for liver-derived secretory proteins using
comprehensive gene expression analyses [8,10,11]. Animal and
cellular experiments showed that LECT2 induces insulin resistance
in the skeletal muscle by activating Jun NH2-terminal kinase (JNK)
[8]. This study demonstrated that LECT2 functions as a hepatokine
linking obesity with skeletal muscle insulin resistance.e under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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the energy depletion-sensing protein adenosine monophosphate-
activated protein kinase (AMPK) [8]. Consistent with ﬁndings in
hepatocytes, we reported that both LECT2 gene expression in the
liver and LECT2 protein levels in bloodwere downregulated in mice
after fasting for 12 h [8]. In contrast, high-fat intake for more than 1
week increased both LECT2 gene expression in the liver and LECT2
protein levels in the blood of mice [8]. These data indicate that
LECT2 is an energy-sensing hepatokine upregulated in response to
overnutrition. However, the responses of LECT2 to rapid and dy-
namic nutritional changes during weight cycling remain unclear.
Based on previous ﬁndings suggesting the inﬂuence of nutri-
tional status on LECT2 expression, we hypothesized that LECT2
expression responds rapidly and dramatically to changes in dietary
content during body weight cycling. To test this hypothesis, we fed
mice a 60% high-fat diet (HFD) and a regular diet (RD) alternately to
generate a mouse model of weight cycling. Serum levels of LECT2
were measured in mice during weight cycling to determine
whether circulating LECT2 precedes alterations in body weight in
response to a change in diet.
2. Materials and methods
2.1. Animals
Male C57BL/6J mice (6 weeks old) were obtained from Sankyo
Laboratory Service (Tokyo, Japan). Mice were housed under a 12-h
light/dark cycle and allowed free access to food and water. Mice
were fed a RD (CRF-1; Oriental Yeast Co., Ltd., Tokyo, Japan) or a 60%
HFD (D12492; Research Diets, Inc., New Brunswick, NJ, USA). The 25
mice were divided randomly into three groups: the RD, HFD, and
WC groups. RD and HFD mice were continuously fed a RD and HFD,
respectively, throughout the experimental period. WC mice were
initially fed a HFD for 3 months to induce obesity. Then, the mice
were switched from a HFD to RD for 1month to lose body weight to
a similar level as that in the RD mice. Finally, the WC mice were
shifted from a RD to HFD to regain body weight to a similar level as
that in the HFD mice. During the time course of the experiment,
blood samples were obtained via the tail vein under fed conditions.
When the experiment ended, after fasting for 12 h, mice were
anesthetized and sacriﬁced to isolate the organs and blood. The
blood was sampled by cardiac puncture. The serum was separated
by centrifugation at 4 C and stored at 80 C until analysis. All of
the animal studies were carried out in accordance with the
Guidelines for the Care and Use of Laboratory Animals issued by
Kanazawa University. The protocol was approved by the ethics
committee of Kanazawa University (Approval no. 143206).
2.2. Blood sample assays
Serum LECT2 levels were measured using the Ab-Match AS-
SEMBLY Mouse LECT2 kit (MBL International, Woburn, MA, USA).
Fasting serum insulin levels were measured using a mouse insulin
ELISA kit (Morinaga Institute of Biological Science, Inc., Yokohama,
Japan) in accordance with the manufacturer's instructions.
2.3. Quantitative real-time PCR
Total RNA was extracted from mouse liver and adipose tissue
using the High Pure RNA Tissue Kit (Roche, Basel, Switzerland) and
RNeasy Lipid Tissue Mini Kit (Qiagen, Hilden, Germany). Reverse
transcription of total RNA was performed with the High-capacity
cDNA Reverse Transcription Kit (Life Technologies, Carlsbad, CA,USA). Real-time PCR analysis was performed as described previ-
ously [10]. Primer sets and TaqMan probes for each gene were
purchased as Assays-on-Demand Gene Expression Products
(Applied Biosystems, Foster City, CA, USA).
2.4. Measurement of liver triglyceride content
After liver tissue weight was measured, liver tissue was ho-
mogenized in 2 mL isopropanol on ice. The samples were incubated
for 10 min with shaking at room temperature and centrifuged at
3000 rpm for 10 min 1 mL supernatant was used to measure the
hepatic triglyceride content using the Triglyceride E-test WAKO kit
(WAKO Pure Chemical Industries, Osaka, Japan), normalized rela-
tive to the liver weight in each sample.
2.5. Adipose tissue assay
Adipose tissue was collected from the epididymal fat of mice.
The tissues were stained with hematoxylin and eosin. Adipocyte
diameters were measured in 600 cells per mouse (n ¼ 3). Histo-
grams were constructed based on 1800 cells/group.
2.6. Statistical analysis
All analyses were performed with the Japanese Windows Edi-
tion of SPSS (SPSS Inc., Chicago, IL, USA). Results are expressed as
means ± standard error of the mean (SEM). Differences among the
three groups were tested by one-way analysis of variance (ANOVA)
with Turkey's method. Scatter plots of LECT2 levels and metabolic
parameters were analyzed using Spearman's correlation coefﬁ-
cient. In all analyses, p < 0.05 was taken to indicate statistical
signiﬁcance.
3. Results
3.1. Generation of a mouse model of weight cycling
To generate a model of weight cycling in mice (WC mice), we
alternated the mice between a HFD and RD (Fig. 1A). WC mice were
initially fed a HFD for 3months to induce obesity (Fig.1B). Then, the
mice were switched from a HFD to RD to lose the weight gain. After
feeding a RD for 1 month, WC mice showed a gradual reduction in
body weight to that seen in mice fed a RD continuously throughout
the study (RDmice) (Fig. 1C). Finally, WC mice were switched again
from a RD to HFD to induce weight regain. After refeeding the HFD
for 40 days, WC mice showed a gradual increase in body weight
similar to that in mice fed a HFD continuously throughout the study
(HFD mice) (Fig. 1D).
3.2. Rapid response of circulating LECT2 in WC mice
We assessed changes in serum levels of LECT2 during weight
cycling. Prior to commencement of weight cycling, LECT2 levels
were higher in HFDmice than those in RDmice, consistent with our
previous report [8]. However, whenWCmice were switched from a
HFD to RD, serum LECT2 decreased rapidly, within 10 days, to a
similar level as that seen in RD mice (Fig. 1G). Similarly, when WC
mice were switched from a RD to HFD to induce weight regain,
serum LECT2 levels increased rapidly. However, serum LECT2 in the
WC mice did not reach the levels observed in HFD mice, even after
HFD feeding for 40 days, at which time no differences in body
weight were evident between WC and HFD mice (Fig. 1G). These
results indicate that circulating LECT2 responds rapidly to dietary
Fig. 1. Serum LECT2 responded rapidly to diet-induced body weight cycling in mice. In cycle 1, mice undergoing weight cycling (WC mice) were fed a high-fat diet (HFD) for 3
months to induce obesity. Then, in cycle 2, WC mice were switched from a HFD to a regular diet (RD) for 1 month to lose body weight. Finally, in cycle 3, WC mice were switched
from a RD to HFD to induce weight regain. RD and HFD mice were fed a RD and HFD, respectively, continuously throughout the study. (A) Changes in body weight. (BeD) Body
weight at the end of cycle 1 (B), end of cycle 2 (C), and end of cycle 3 (D). (E, F) Food intake in cycle 2 (E) and cycle 3 (F). (G) Changes in serum levels of LECT2 in mice from each
group during weight cycling. Data are shown as means ± standard error of the mean (SEM) (n ¼ 7e9 per group). *p < 0.05, **p < 0.01, ***p < 0.001 RD vs. WC; and yp < 0.05,
yyp < 0.01, yyyp < 0.001 HFD vs. WC in (A) or as indicated. ns: not signiﬁcant, one-way ANOVA with Tukey's post hoc test.
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during weight cycling in mice.3.3. Reductions in levels of circulating LECT2 and insulin in WC
mice compared with HFD mice
We assessed several parameters at the end of the weight cycling
experiment. HFD mice showed increases in serum LECT2, hepatic
LECT2, serum insulin, and serum glucose levels compared with RD
mice (Fig. 2AeD). However, WC mice showed a reduction in serum
LECT2 levels compared with HFD mice under both fasted and fed
conditions (Fig. 2A). Consistent with the ﬁndings in serum, LECT2
mRNA levels were decreased in the liver ofWCmice comparedwith
HFD mice (Fig. 2B). In addition, serum levels of insulin tended to be
decreased in WC mice compared with HFD mice, although blood
glucose levels were unchanged (Fig. 2C and D). These results sug-
gest that weight cycling attenuates LECT2 overproduction and in-
sulin resistance induced by persistent HFD feeding despite a similarnet body weight gain between WC and HFD mice.3.4. Decreased fat accumulation in the liver of WC mice
As a previous clinical study reported elevated serum LECT2
levels in humans with fatty liver [12], we examined liver fat accu-
mulation in mice. HFDmice showed an increase in liver triglyceride
content compared with RD mice. However, weight cycling partly
alleviated the persistent HFD-induced increase in liver triglyceride
content (Fig. 2E). Consistent with the triglyceride contents, hepatic
gene expression of sterol regulatory element binding protein-1c
(encoded by Srebf1), a master regulator of fatty acid synthesis
[13], tended to be decreased in WC mice compared with HFD mice
(Fig. 2F). Peroxisome proliferator-activated receptor-g (PPAR-g;
encoded by Pparg), a positive regulator of hepatic steatosis [14], was
also decreased in expression in WC mice compared with HFD mice
(Fig. 2G). However, gene expression of carnitine palmitoyl trans-
ferase 1a (encoded by Cpt1a), a mitochondrial membrane protein
Fig. 2. Diet-induced weight cycling attenuated LECT2 overproduction and liver fat accumulation in mice. Blood and liver samples were obtained from mice at the end of the
weight cycling experiments. (A) Serum levels of LECT2 under fed and fasted conditions. (B) mRNA expression of LECT2 in the liver. (C, D) Serum levels of insulin (C) and glucose (D)
in the mice of each group. Insulin and glucose levels were measured under fasted conditions. (E) Triglyceride contents in liver tissues. (FeH) mRNA levels of Srebf1 (SREBP-1c) (F),
Pparg (G), and Cpt1a (H) in the livers of mice in each group. Data are shown as means ± SEM (n ¼ 7e9 per group). *p < 0.05, **p < 0.01, ***p < 0.001 as indicated, one-way ANOVA
with Tukey's post hoc test.
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unchanged (Fig. 2H). These results suggest that weight cycling at-
tenuates liver fat accumulation induced by persistent HFD feeding
despite a similar net body weight gain between WC and HFD mice.3.5. Increased adipose tissue in WC mice
Next, we examined the effects of weight cycling on adipose
tissue in mice. HFD mice showed increased epididymal fat weight
compared with RD mice (Fig. 3A). However, WC mice showed a
further increase in epididymal fat weight compared with HFD mice
(Fig. 3A). Consistent with these observations, adipocyte diameter
was increased inWCmice compared with HFDmice (Fig. 3B and C).
Next, we assessed gene expression associated with adipocyte
biology in epididymal fat tissue. HFD feeding decreased gene
expression of Pparg, a master regulator of adipogenesis, and adi-
ponectin (encoded by Adipoq), a PPAR-g-upregulated adipocyto-
kine [16], compared with RD feeding (Fig. 3D and E). However, WC
mice showed no alterations in the expression of these two genes
(Fig. 3D and E) compared with HFD mice. Gene expression of fatty
acid synthase (encoded by Fasn), a key enzyme involved in de novo
fatty acid synthesis [17], and CD36 (encoded by Cd36), a high-afﬁnity receptor that promotes uptake of long-chain fatty acids
[18], was unchanged in WC mice compared with HFD mice (Fig. 3F
and G). In contrast to liver fat accumulation, these results suggest
that weight cycling further promotes adipocyte hypertrophy
compared with persistent HFD feeding despite a similar net body
weight gain between WC and HFD mice.3.6. Correlation between serum LECT2 and overnutrition markers
Finally, we examined the relationship between serum LECT2
levels and various overnutrition-related parameters in all mice of
the three groups. Serum levels of LECT2 showed positive correla-
tions with body weight, serum insulin level, blood glucose level,
and liver triglyceride content (Fig. 4AeD). However, there was no
correlation between serum LECT2 levels and epididymal fat weight
(Fig. 4E). These results indicate that circulating LECT2 represents an
overnutrition marker, apart from adipose tissue weight, of weight
cycling in mice.4. Discussion
The present study reveals a rapid response of circulating
Fig. 3. Diet-induced weight cycling further increased adipose tissue weight in mice. (A) Epididymal fat weight in the mice of each group. (B) Histogram showing adipocyte
diameters in the mice of each group. (C) Diameters of adipocytes of epididymal fat tissue from mice of each group. The diameters of 600 cells/mouse were measured (n ¼ 3/group).
(DeG) mRNA levels of Pparg (D), Adipoq (E), Fasn (F), and Cd36 (G) in adipose tissues from mice of each group. Data are shown as means ± SEM (n ¼ 7e9 per group). *p < 0.05,
**p < 0.01, ***p < 0.001 as indicated, ns: not signiﬁcant, one-way ANOVA with Tukey's post hoc test.
Fig. 4. Serum LECT2 is positively correlated with liver fat content but not with adipose tissue weight. (AeE) Correlations between serum LECT2 levels and body weight (A),
serum insulin levels (B), serum glucose levels (C), triglyceride contents in liver tissue (D), and epididymal fat weight (E). Epididymal fat weight did not show a signiﬁcant correlation
with serum LECT2 levels. The data were analyzed using Spearman's coefﬁcient of correlation. Statistical signiﬁcance was accepted at p < 0.05. ns: not signiﬁcant.
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weight alterations induced by switching dietary content. In clinical
settings, rapid turnover proteins (RTPs), such as prealbumin and
retinol binding protein, have been used as nutritional markers in
patients with various diseases [19e21]. As RTPs show rapid syn-
thesis and short half-lives, decreases in blood RTP levels represent
protein energy malnutrition. Thus, the measurement of blood RTP
levels is performed mainly in patients with wasting diseases to
assess the need for additional nutritional support [20]. To our
knowledge, however, few clinical markers are available for over-
nutrition conditions, such as obesity and type 2 diabetes. The
present data suggest that circulating LECT2 can be used as a rapid
serum marker of overnutrition to predict body weight cycling.
Further studies in obese subjects attempting to lose body weight
are needed to determine the clinical usefulness of serum LECT2
measurements.
In comparison with persistent HFD feeding, weight cycling
attenuated LECT2 production, liver fat accumulation, and hyper-
insulinemia but increased visceral adipose tissue mass and adipo-
cyte hypertrophy. The present ﬁndings were consistent with a
previous report showing long-lasting improvements in liver fat and
insulin resistance in overweight humans who experienced body
weight regain after dietary weight loss [22]. Our results suggest
that the effects of a calorie-restricted diet on fatty liver may
continue even after the onset of acute weight regain. On the other
hand, early evidence suggested that weight cycling induces further
adipose tissue expansion, probably due to an increase in fat storage
efﬁciency in the adipose tissue [23,24]. Fat storage efﬁciency during
the energy recovery period may differ markedly between the liver
and adipose tissue. WC mice tended to show improvement in
hyperinsulinemia, a representative marker of insulin resistance,
despite adipocyte hypertrophy, which has been reported to play a
central role in the onset of metabolic disorders in obesity [25]. As
we previously reported that the hepatokine LECT2 induces insulin
resistance in skeletal muscle directly [8], we speculate that sup-
pression of LECT2 will improve insulin resistance to counteract
adipocyte hypertrophy in WC mice. The present data support the
concept that hepatic steatosis and abnormal release of hepatokines
contribute to the development of insulin resistance and glucose
intolerance independently of adipose tissue expansion and adipo-
cyte hypertrophy [8,11,26].
In this study, serum LECT2 levels showed a strong positive
correlation with liver triglyceride content but not with epididymal
fat weight. LECT2 was identiﬁed as a liver-derived secretory pro-
tein, the expression of which is positively correlated with BMI, a
marker of the severity of obesity in humans [8]. However, it was
unclear which types of tissue fat accumulation are correlated with
circulating levels of LECT2. Our results indicate that circulating
LECT2 levels are a marker of the severity of liver fat content, but not
adipose tissue mass, in mice. Our ﬁndings were consistent with a
previous report showing elevation of blood LECT2 in patients with
fatty liver, as assessed by abdominal ultrasonography [12]. The
strong correlation between circulating LECT2 levels and liver fat
may be explained by a common pathology, i.e., AMPK inactivation
induces both LECT2 overproduction and fat accumulation in he-
patocytes [8,27]. In clinical settings, liver fat content in humans is
quantiﬁed by several methods, including liver biopsy, magnetic
resonance spectroscopy, computed tomography, and ultrasonog-
raphy [28e30]. However, many of these methods require expensive
equipment or highly invasive approaches. Further clinical in-
vestigations will provide insight into the usefulness of circulating
LECT2 measurements for quantiﬁcation of hepatic steatosis in
humans.
Several limitations of this study should be taken into consider-
ation. First, because the blood samples obtained from mice duringthe weight-cycling period were low in volume, we were unable to
measure blood markers other than LECT2, such as insulin or other
RTPs, during weight cycling. Second, the number of body weight
cycles was small in our experiments. A previous report indicated
that diet-induced body weight cycling for more than eight cycles
signiﬁcantly increased body weight and liver triglyceride contents
compared with persistent HFD feeding in mice [24]. Additional
studies are needed to determine the effects of recurrent body
weight cycling on LECT2 production and fat accumulation in the
liver.
In conclusion, the present study demonstrates the rapid
response of serum LECT2 to dietary changes, and these changes
precede body weight alterations during diet-induced weight
cycling in mice, suggesting that measurement of serum LECT2
levels may be clinically useful for body weight management in
obese individuals.
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